Chaga
The Birch Fungus of the Northern Forests
Evidence grade 1 of 5, Untested. Read how the Atlas grades evidence.
Chaga's evidence is mostly preclinical, real signals in the lab, little in people. Studies have shown IOP lowering blood sugar in mice, chaga extracts inhibiting human cancer cells in vitro, and antioxidant and immune effects in cell and animal models. What is largely missing is rigorous human clinical trial data, so claims that chaga treats or prevents cancer, diabetes, or other diseases in people are not supported by good evidence. The honest framing: a long-used northern folk tonic with interesting laboratory pharmacology and a real antioxidant profile, but without the human trials to confirm the disease-related benefits often advertised, and notably less human evidence than turkey tail (PSK) or lion's mane.
Reference only. Not medical advice.
What can go wrong
The stand-out risk is the kidneys. Chaga is very high in oxalates, and published case reports link heavy or prolonged use to oxalate nephropathy: a 69-year-old man taking 10 to 15 grams of powder daily with vitamin C for three months developed acute kidney injury needing emergency dialysis (Medicine, 2022), and a 49-year-old man taking 3 to 9 grams daily for five years reached end-stage kidney disease and lasting dialysis (Journal of Korean Medical Science, 2020). Anyone with kidney disease, a kidney-stone history, or who takes high-dose vitamin C should be especially cautious, and heavy daily intake is not advisable. Chaga may also lower blood sugar (caution alongside diabetes medication) and may increase bleeding risk (caution with anticoagulants or antiplatelet drugs and before surgery), and because it engages the immune system it warrants care with autoimmune conditions or immunosuppressants. Wild-harvested chaga can be misidentified or contaminated. Because of the interaction and kidney concerns, anyone considering regular chaga, and especially those who are pregnant, nursing, managing a chronic illness, or on prescription medication, should first talk with a qualified healthcare provider.
Chaga is the sterile conk of Inonotus obliquus, a fungus that grows on birch trees in cold northern forests and looks like a lump of burnt charcoal on the trunk. For centuries it was brewed into a bitter tea across Siberia, Russia, and the boreal north, a cold-climate parallel to the medicinal mushrooms of East Asia. Laboratory work has found real antioxidant content plus polysaccharides and triterpenes with antioxidant, immune, blood-sugar, and anti-tumor activity in cells and mice, but essentially no human trials exist, so marketing that says chaga treats cancer or diabetes in people is not supported. It also carries a hazard that sets it apart from most mushrooms: it is very high in oxalates, and published case reports link heavy or prolonged use to kidney injury, including one patient who progressed to permanent dialysis.
A birch-tree fungus of the northern forests, a real antioxidant folk tonic with mostly lab-stage evidence and a notable oxalate-kidney risk at high intake.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Chaga is rich in antioxidants and contains polysaccharides (including an Inonotus obliquus polysaccharide, IOP), beta-glucans, and triterpenes that show antioxidant, immune-modulating, anti-inflammatory, and, in the lab, blood-sugar-lowering and anti-tumor activities. These provide plausible bases for its traditional tonic uses, but, as with most medicinal mushrooms, the gap between cell/animal findings and human outcomes is wide.
What people get wrong
Often saidChaga is a proven cancer and diabetes remedy.
ActuallyThe anti-tumor and blood-sugar effects are seen in cell cultures and mice, not in human trials. Memorial Sloan Kettering states that the safety and efficacy of chaga have yet to be evaluated in clinical studies, and review articles find no completed human efficacy trials, so disease-treatment claims are unsupported.
Often saidChaga tea is a harmless daily health drink you can never overdo.
ActuallyChaga is very high in oxalates. Published case reports link heavy or prolonged use to oxalate nephropathy: one 49-year-old man who took 3 to 9 grams daily for five years progressed to end-stage kidney disease and permanent dialysis (Journal of Korean Medical Science, 2020).
Often saidChaga is an ancient East Asian medicinal mushroom like reishi or lion's mane.
ActuallyIts documented deep roots are in the boreal north, among Siberian and Ural peoples such as the Khanty and in Russian and Northern European folk medicine, an independent cold-forest tradition rather than an offshoot of the East Asian materia medica.
Often saidThe Soviets scientifically proved chaga cures cancer, and the West has ignored it.
ActuallyThe USSR approved a standardized extract, Befungin, in 1955, but approval as a folk preparation is not the same as demonstrated efficacy. That mid-century regulatory step was not built on modern controlled human trials, which still do not exist.
Who profits, and who pushes back
Preclinical researchers
Report antioxidant, immune, blood-sugar-lowering, and anti-tumor effects of chaga extracts in cells and mice, while noting rigorous human evidence is lacking.
Northern folk traditions
Have used birch chaga as a bitter tonic tea for digestion, inflammation, and vitality for centuries across the northern forests.
Nephrology case reports
Document kidney damage, including oxalate nephropathy and failure, linked to heavy or prolonged chaga consumption, given its very high oxalate content.
Functional-mushroom marketing
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Promotes chaga with broad antioxidant, immune, and anti-disease claims that outrun the human evidence, often alongside East Asian mushrooms, with a commercial interest.
Where the research comes from
Most of the published research on this comes from one place. 85% of it is from Siberia & Russia. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Siberia & Russia | 85% |
| Northern & Eastern Europe | 75% |
| Boreal North America | 60% |
| Global supplement market | 55% |
How we got here
Chaga's story is a northern one. The Khanty and other Indigenous peoples of western Siberia and the Ural region are credited with the oldest recorded use, brewing the birch conk into tea and burning it in ritual and household care; the word itself comes from Komi-Permyak. Russian folk medicine records chaga from at least the 16th century for stomach complaints and as a general tonic, and closely related tinder fungi were prized across the boreal world for fire-starting, with birch polypore found among the 5,000-year-old Iceman's possessions in the Alps. Soviet science took it seriously in the 1950s: in 1955 the USSR Ministry of Health approved a standardized chaga extract, Befungin. That approval fed into culture too, Aleksandr Solzhenitsyn, treated for cancer while in exile, wove a doctor who champions birch-fungus tea into his 1966 novel Cancer Ward. Global functional-mushroom marketing arrived only in the 2010s and 2020s.
- c. 12th-16th centuryKhanty and other Ural/Siberian peoples use birch chaga as tea and in ritual; term derives from Komi-Permyak
- 1500sRussian folk medicine records chaga for gastric complaints and as a general tonic
- 1955USSR Ministry of Health approves the standardized chaga extract Befungin as an official preparation
- 1966Solzhenitsyn's Cancer Ward features Dr. Maslennikov, who writes to the hero about birch-fungus tea for cancer
- 2000s-2010sLab and animal studies characterize antioxidant, polysaccharide, and triterpenoid activity
- 2014-2022Case reports document chaga-associated oxalate nephropathy (Japan 2014; Korea 2020; Medicine 2022)
- 2010s-2020sChaga enters the global functional-mushroom market as teas, powders, and extracts
How it is understood
Chaga (Inonotus obliquus) is not a soft-capped mushroom but a hard, charcoal-like mass that grows on birch trees in cold northern forests. It has a long folk history across Siberia, Russia, the Baltic and Nordic regions, and among some boreal Indigenous peoples, brewed as a bitter tea or tonic and used for digestion, inflammation, and general vitality, with documented European medicinal use reaching back centuries. It is the cold-climate counterpart to the East Asian medicinal mushrooms, a forest remedy of the north rather than the Chinese pharmacopeia, and has recently joined the global "functional mushroom" market as a tea and supplement.
At a glance
- Fungus
- Inonotus obliquus (on birch)
- Roots
- Siberian/Northern European/boreal folk use
- Evidence
- Mostly preclinical (lab/animal)
- Key risk
- High oxalate, kidney damage at high intake
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Chaga. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
Chaga safety and efficacy not evaluated in clinical studies; kidney cases; anticoagulant and hypoglycemic interactions; provider caution
Memorial Sloan Kettering Cancer Center, About Herbs: Chaga Mushroom
69-year-old man, 10-15 g/day chaga powder plus vitamin C for 3 months, acute kidney injury with nephrotic syndrome, calcium oxalate crystals on biopsy, required hemodialysis
49-year-old man, 3-9 g/day chaga for 5 years for atopic dermatitis, end-stage renal disease with oxalate crystal deposits; second case worldwide, first in Japan 2014
Chaga evidence is preclinical (in vitro and animal); antioxidant polyphenols, alpha-glucosidase inhibition stronger than acarbose, anti-inflammatory triterpenoids; 16th-century Siberian and Russian folk use; mechanisms not well understood
Duru et al., Therapeutic properties of Inonotus obliquus (Chaga mushroom): A review (PMC11132974)
In vitro anticancer activity of chaga against human lung, breast, stomach, cervical, and liver cancer cell lines; clinical significance yet unknown
Solzhenitsyn's 1966 novel Cancer Ward features Dr. Maslennikov, who writes to the hero about birch fungus (chaga) tea for cancer; semi-autobiographical, author treated for cancer in exile
Khanty and Ural peoples' early use of chaga; term from Komi-Permyak; 1955 USSR approval of Befungin; 16th-century Russian folk records
Chaga mushroom: a super-fungus with countless facets and untapped potential (PMC10728660)
Birch polypore and tinder fungi in boreal history; birch polypore among the 5,000-year-old Iceman's possessions; birch-tree habitat
Tinder Fungus: Historical Uses, Identification, and Foraging, Mushroom Appreciation